Induction of Fas receptor and Fas ligand by nodularin is mediated by NF-κB in HepG2 cells

Toxicology and Applied Pharmacology

Volumn 251, Issue 3, 2011, Pages 245-252

  Feng, Gong ^a,b   Li, Ying ^b   Bai, Yansheng ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Anong Biotech Institute   (China)

Author keywords

Apoptosis; Fas; Fas ligand; NF B; Nodularin

Indexed keywords

FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUTRALIZING ANTIBODY; NODULARIN; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TRANSPORT;

ANTIGENS, CD95; APOPTOSIS; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; NF-KAPPA B; PEPTIDES, CYCLIC; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTOR RELA;

EID: 79952004257     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.01.009     Document Type: Article

References (38)

1. Aoudjehane L., Podevin P., Scatton O., Jaffray P., Dusanter-Fourt I., Feldmann G., Massault P.P., Grira L., Bringuier A., Dousset B., Chouzenoux S., Soubrane O., Calmus Y., Conti F. Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J. 2007, 21:1433-1444.
2. Baichwal V.R., Baeuerle P.A. Activate NF-kappa B or die?. Curr. Biol. 1997, 7:R94-R96.
3. Barkett M., Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6910-6924.
4. Bouaicha N., Maatouk I. Microcystin-LR and nodularin induce intracellular glutathione alteration, reactive oxygen species production and lipid peroxidation in primary cultured rat hepatocytes. Toxicol. Lett. 2004, 148:53-63.
5. Carmichael W.W. Toxins of fresh water cyanobacteria. Handbook of Natural Toxins: Marine Toxins and Venoms 1988, 121-147. A. T. T. (Ed.).
6. Carmichael W.W. The cyanotoxins. Advances in Botanical Research 1997, Academic Press, London. J.A. Callow (Ed.).
7. Chan H., Bartos D.P., Owen-Schaub L.B. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol. Cell. Biol. 1999, 19:2098-2108.
8. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505-512.
9. Dittmann E., Wiegand C. Cyanobacterial toxins-occurrence, biosynthesis and impact on human affairs. Mol. Nutr. Food Res. 2006, 50:7-17.
10. Dutta J., Fan Y., Gupta N., Fan G., Gelinas C. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 2006, 25:6800-6816.
11. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 1999, 68:383-424.
12. Fladmark K.E., Brustugun O.T., Hovland R., Boe R., Gjertsen B.T., Zhivotovsky B., Doskeland S.O. Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ. 1999, 6:1099-1108.
13. French L.E., Hahne M., Viard I., Radlgruber G., Zanone R., Becker K., Muller C., Tschopp J. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 1996, 133:335-343.
14. Guicciardi M.E., Gores G.J. Life and death by death receptors. FASEB J. 2009, 23:1625-1637.
15. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 1999, 19:5785-5799.
16. Higashi K., Hiai H., Higashi T., Muramatsu M. Regulatory mechanism of glutathione S-transferase P-form during chemical hepatocarcinogenesis: old wine in a new bottle. Cancer Lett. 2004, 209:155-163.
17. Holtz-Heppelmann C.J., Algeciras A., Badley A.D., Paya C.V. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 1998, 273:4416-4423.
18. Honkanen R.E., Dukelow M., Zwiller J., Moore R.E., Khatra B.S., Boynton A.L. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. Mol. Pharmacol. 1991, 40:577-583.
19. Javitt N.B. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 1990, 4:161-168.
20. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., Peter M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995, 14:5579-5588.
21. Lankoff A., Banasik A., Nowak M. Protective effect of melatonin against nodularin-induced oxidative stress. Arch. Toxicol. 2002, 76:158-165.
22. Lankoff A., Wojcik A., Fessard V., Meriluoto J. Nodularin-induced genotoxicity following oxidative DNA damage and aneuploidy in HepG2 cells. Toxicol. Lett. 2006, 164:239-248.
23. Maher S., Toomey D., Condron C., Bouchier-Hayes D. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol. Cell Biol. 2002, 80:131-137.
24. Mersch-Sundermann V., Knasmuller S., Wu X.J., Darroudi F., Kassie F. Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology 2004, 198:329-340.
25. Mondor I., Schmitt-Verhulst A.M., Guerder S. RelA regulates the survival of activated effector CD8 T cells. Cell Death Differ. 2005, 12:1398-1406.
26. Muller M., Strand S., Hug H., Heinemann E.M., Walczak H., Hofmann W.J., Stremmel W., Krammer P.H., Galle P.R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 1997, 99:403-413.
27. Novac N., Baus D., Dostert A., Heinzel T. Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter. FASEB J. 2006, 20:1074-1081.
28. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993, 364:806-809.
29. Ohgaki R., Matsushita M., Kanazawa H., Ogihara S., Hoekstra D., van Ijzendoorn S.C. The Na+/H+ exchanger NHE6 in the endosomal recycling system is involved in the development of apical bile canalicular surface domains in HepG2 cells. Mol. Biol. Cell 2010, 21:1293-1304.
30. Ohta T., Sueoka E., Iida N., Komori A., Suganuma M., Nishiwaki R., Tatematsu M., Kim S.J., Carmichael W.W., Fujiki H. Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Cancer Res. 1994, 54:6402-6406.
31. Rinehart K.L., Harada K., Namikoshi M., Chen C., H.C.A., Munro M.H.G., Blunt J.W., Mulligan P.E., Beasley V.R., et al. Nodularin, microcystin, and the configuration of Adda. J. Am. Chem. Soc. 1988, 110:8557-8558.
32. Rouquet N., Carlier K., Briand P., Wiels J., Joulin V. Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem. Biophys. Res. Commun. 1996, 229:27-35.
33. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 2006, 25:6685-6705.
34. Sivonen K., Jones G. Cyanobacterial toxins. Toxic Cyanobacteria in Water. A Guide to Their Public Health Consequences, Monitoring and Management 1999, 44-111. E & FN Spon on behalf of WHO. I. Bartram (Ed.).
35. Solstad T., Fismen L., Garberg H., Fladmark K.E. Identification of a novel phosphorylation site of acyl-CoA binding protein (ACBP) in nodularin-induced apoptotic hepatocytes. Exp. Cell Res. 2008, 314:2141-2149.
36. van der Wouden J.M., van I.S.C., Hoekstra D. Oncostatin M regulates membrane traffic and stimulates bile canalicular membrane biogenesis in HepG2 cells. EMBO J. 2002, 21:6409-6418.
37. van I.S.C., Zegers M.M., Kok J.W., Hoekstra D. Segregation of glucosylceramide and sphingomyelin occurs in the apical to basolateral transcytotic route in HepG2 cells. J. Cell Biol. 1997, 137:347-357.
38. Yoshizawa S., Matsushima R., Watanabe M.F., Harada K., Ichihara A., Carmichael W.W., Fujiki H. Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity. J. Cancer Res. Clin. Oncol. 1990, 116:609-614.